Keyphrases
Activator protein-1 (AP-1)
15%
AP-1 Pathway
100%
Binding Site
7%
CD147
100%
CD33
7%
Cell Recruitment
7%
Cell Transformation
7%
Chemokines
7%
ChIP Assay
15%
Cutaneous Squamous Cell Carcinoma (cSCC)
15%
CXCL1
30%
Differentially Expressed Genes
7%
DMBA-TPA
15%
Epidermis
100%
Essential Function
7%
Flow Cytometry
7%
HaCaT Cells
7%
Immunohistochemistry
7%
Immunoprecipitation Assay
7%
Infiltration
7%
Interaction Partner
7%
Keratinocytes
7%
Knockdown
7%
Malignant Transformation
100%
Mouse Model
15%
Myeloid-derived Suppressor Cells
38%
Overexpression
23%
Quantitative PCR
7%
RNA Sequencing (RNA-seq)
7%
RSK Inhibitor
7%
RSK2
100%
Serine-threonine Kinase
7%
Spontaneous Tumors
7%
Transcriptional Activation
7%
Transgenic Mice
15%
Transgenic Mouse Model
7%
Tumor
7%
Tumor Formation
7%
Tumor Growth
7%
Tumor Initiation
7%
Tumor Size
7%
Tumorigenesis
7%
Biochemistry, Genetics and Molecular Biology
Binding Site
16%
Carcinogenesis
33%
CD33
16%
Cell Transformation
16%
Chemokine
16%
CXCL1
66%
Cytokine
16%
Electrophoretic Mobility Shift Assay
33%
Flow Cytometry
16%
Immunoprecipitation
16%
In Vivo Study
16%
Keratinocyte
16%
Kinase
16%
Malignant Transformation
100%
Mouse Model
50%
Myeloid
100%
Phosphotransferase
16%
Promoter Region
16%
Real-Time Polymerase Chain Reaction
16%
RNA Sequence
16%
Serine
16%
Threonine
16%
Transcription Initiation
16%
Transgenic Mouse
50%
Tumor Initiation
16%
Tumor Progression
16%
Immunology and Microbiology
Binding Site
20%
CD33
20%
Cell Transformation
20%
Chemokine
20%
CXCL1
80%
Cytokine
20%
Gel Mobility Shift Assay
40%
Immunoprecipitation
20%
Keratinocyte
20%
Mouse Model
60%
Myeloid
20%
Myeloid-Derived Suppressor Cell
100%
Promoter Region
20%
Real-Time Polymerase Chain Reaction
20%
RNA Sequence
20%
Squamous Cell
40%
Transcription Initiation
20%
Transgenic Mouse
60%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Site
20%
Carcinogenesis
40%
Chemokine
20%
Cytokine
20%
Dimethylbenz[a]anthracene
40%
Electrophoretic Mobility Shift Assay
40%
Flow Cytometry
20%
Immunoprecipitation
20%
Malignant Transformation
100%
Mouse Model
60%
Neoplasm
60%
Protein Serine Threonine Kinase
20%
RNA-Sequencing
20%
Skin Carcinoma
40%
Transgenic Mouse
60%
Tumor Growth
20%